Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 84.88% | 48.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 66.21% | 28.41% | |||
| Operating Income | -66.21% | -28.41% | |||
| Income Before Tax | -67.93% | -30.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67.93% | -30.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -67.93% | -30.98% | |||
| EBIT | -66.21% | -28.41% | |||
| EBITDA | -66.34% | -28.47% | |||
| EPS Basic | -67.94% | -30.79% | |||
| Normalized Basic EPS | -67.92% | -30.86% | |||
| EPS Diluted | -67.94% | -30.79% | |||
| Normalized Diluted EPS | -67.92% | -30.86% | |||
| Average Basic Shares Outstanding | 0.02% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||